Omar N. Lweno

In the News

Chief Operation Officer – COO required at IHI

(Dar es Salaam) IHI is looking for an experienced individual to take the position of Chief Operating Officer (COO). Reporting to the Chief Executive Director (CED), the COO will play …

IHI hosts WaSH collaborators from South Africa

(Dar es Salaam) South Africa’s collaborators in the Leading Integrated Research for Agenda (LIRA) 2030 project visited Ifakara Health Institute (IHI) and a number of sites where the project is …

Recent Projects

Sustainable, Healthy, Learning Cities and Neighbourhoods

The Sustainable, Healthy, Learning Cities and Neighbourhoods is an exciting project in which IHI works with a consortium of partners from Asia and Africa to 1) develop capacity for improved …

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Omar N. Lweno

Research Scientist

Dr. Omar N. Lweno has over 10 years of experience in clinical patient care and supervision of health services. He has also served as coordinator of Care and Treatment Clinic for People living with HIV/AIDS which was technically supported by the Elizabeth Glaser Paediatric HIV Foundation  (EGPAF). He has served as a study clinician in a number of drug trials evaluating Artemisinin-based combination therapies (ACTs),  and Bioequivalence studies. His research experience include malaria vaccine trials from phase 1 trials of Controlled Human Malaria Infection by PfSPZ- Sporozoite challenge and p27A antigen to phase 3 multicentre trial of the RTS,s candidate malaria vaccine as Safety Clinician. He has worked as Co-investigator in the IDEA-Tz project part of the international consortium examining the immunological interaction between Helminths/Malaria and Helminths/HIV.  He also served as Co-investigator in the recently completed “Human monoclonal antibodies study to aid antigen discovery and prioritization for malaria vaccine development” among pregnant women with malaria  in collaboration with  the National Institute of Medical Research (NIMR) and University of Cape Town. Dr. Lweno is the Principal Investigator of a phase 3 clinical trial comparing Intravenous Ferric Carboxymaltose (Ferinject) to Oral iron in the treatment of iron deficiency anemia at delivery in Tanzania(ClinicalTrials.govID: NCT02541708). This is a collaborative study between Ifakara Health Institute and Swiss Tropical and Public Health Institute (Swiss TPH).

View Dr. Lweno’s Research Interests and Publications


Evaluation of intravenous iron supplementation compared to oral supplementation among women with iron-deficient anemia

© Ifakara Health Institute (IHI), 2016